News and Press Releases
Press releases
Theralase Launches Next Generation Therapeutic Laser in USA
Toronto, Ontario – November 26, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0FDA Grants Approval for Next Generation Therapeutic Laser
Toronto, Ontario – November 25, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0Theralase Appoints Director of Clinical Education / Training and Clinic Director
Toronto, Ontario – November 24, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0Theralase Anti-Cancer Technology Presented at International Laser Conference
Toronto, Ontario – November 10, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0Theralase Partners with University of Ulm ( Located in Germany)
Toronto, Ontario – November 12, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0Theralase Completes GMP Manufacture of Second Batch of Lead Drug
Toronto, Ontario – October 1, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechn...
0Theralase Submits Anti-Cancer Technology to Research Ethics Board for Approval
Toronto, Ontario – September 21, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Submits Investigational Testing Authorization to Health Canada for Approval
Toronto, Ontario – September 18, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Submits Clinical Trial Application to Health Canada for Approval
Toronto, Ontario – September 17, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Completes Detailed Information on the TLC-3000B Laser System
Toronto, Ontario – September 15, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
